Inspire Corporate Bond Impact ETF (IBD): Price and Financial Metrics ETF

Inspire Corporate Bond Impact ETF (IBD): $23.85

0.02 (+0.08%)

POWR Rating

Component Grades

Buy & Hold

A

Peer

D

Add IBD to Watchlist
Sign Up

Category: Corporate Bond ETFs

Category

C

Ranked

#40 of 95

in category

IBD Price/Volume Stats - 7 Best ETFs for the NEXT Bull Market

Current price $23.85 52-week high $25.49
Prev. close $23.83 52-week low $22.99
Day low $23.72 Volume 32,224
Day high $23.90 Avg. volume 84,691
50-day MA $23.78 Dividend yield 4.1%
200-day MA $23.61

IBD Stock Price Chart Interactive Chart >


Inspire Corporate Bond Impact ETF (IBD) ETF Bio


The investment objective of the Inspire Corporate Bond Impact ETF seeks to provides a low cost, convenient, index-based way for investors to create a purposeful impact by supporting causes such as clean water projects, Bible distribution, efforts to stop human trafficking, and humanitarian relief for refugees. The funds underlying Inspire Corporate Bond Impact Equal Weight Index is comprised of 250 investment grade short term and intermediate term corporate bonds issued by some of the most inspiring large cap "blue chip" companies in the U.S., as determined by Inspire's innovative Inspire Impact Score methodology, which measures a company's positive impact on the world. The index is equally weighted, rebalanced quarterly and calculated on a total return basis in U.S. dollars.

IBD ETF Info

Issuer Inspire ETFs
Expense Ratio 0.44%
Underlying Index Inspire Corporate Bond Impact Equal Weight Index
Asset Class Fixed Income
Sector Corporate Bond ETFs
Assets Under Management (AUM) 335.72M
Net Asset Value (NAV) $23.81
Options? Yes
Total Holdings 35

IBD Price Returns

1-mo 0.87%
3-mo -0.36%
6-mo 3.58%
1-year 7.34%
3-year 1.21%
5-year 4.26%
YTD 4.87%
2023 6.01%
2022 -8.94%
2021 -1.89%
2020 5.15%
2019 7.74%

IBD Dividends

Ex-Dividend Date Type Payout Amount Change
Loading, please wait...
View Full IBD Dividend History

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!